Eyal Flom

Eyal Flom

Director/Board Member at INNOCAN PHARMA CORPORATION

Net worth: 113 648 $ as of 2026-05-30

61 year
Health Technology
Consumer Services
Distribution Services

Profile

Eyal Flom currently serves as Secretary, Director & General Counsel at InnoCan Pharma Corp.
since 2020, Director at NurExone Biologic Ltd., and Legal Counsel at the Israeli Pharmaceutical Association since 1995.
Former positions include Director at NurExone Biologic, Inc. from 2020 to 2022 and Director at Revium Recovery, Inc. from 2021 to 2024.
Education includes an MBA from the University of Derby and graduate studies at Tel-Aviv University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-07-01 42,014 ( 0.93% ) 113 648 $ 2026-05-30

Eyal Flom active positions

CompaniesPositionStart
INNOCAN PHARMA CORPORATION Director/Board Member 2019-09-24
Israeli Pharmaceutical Association
General Counsel 1995-03-31
Director/Board Member -

Former positions of Eyal Flom

CompaniesPositionEnd
REVIUM RX. Director/Board Member 2024-11-30
NUREXONE BIOLOGIC INC. Director/Board Member 2022-04-30
See the detail of Eyal Flom's experience

Training of Eyal Flom

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

1

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Distribution Services

Consumer Services

Consumer Services

Health Technology

Israeli Pharmaceutical Association

Commercial Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!